Effect of Nilacid treatment in ulcer.
Figus
A I
AI
Papp
I
I
Bajza
Y
Y
D000328:Adult; D000863:Antacids / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008276:Magnesium Hydroxide / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000627:therapeutic use*; D012824:Silicic Acid / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000188:drug therapy*
D000863:Antacids; D004338:Drug Combinations; D010710:Phosphates; C052288:Nilacid antacid; D012824:Silicic Acid; D012822:Silicon Dioxide; D008274:Magnesium; D008276:Magnesium Hydroxide; D001729:Bismuth